Zhao et al developed biocompatible lipid-polymer hybrid nanoparticles for the co-delivery of HIF1a siRNA (si-HIF1a) and Gemcitabine for the treatment of pancreatic cancer. Here, HIF1A is linked to pancreatic neoplasm.